rs1131692258
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001375380.1(EBF3):c.486-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001375380.1 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EBF3 | NM_001375380.1 | c.486-1G>A | splice_acceptor_variant, intron_variant | Intron 5 of 16 | ENST00000440978.2 | NP_001362309.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hypotonia, ataxia, and delayed development syndrome Pathogenic:1
- -
not provided Pathogenic:1
The c.486-1G>A variant in the EBF3 gene has been observed in internal GeneDx whole exome sequencing data in association with intellectual disability, autistic features, hypotonia, short stature, vermis hypoplasia, and facial dysmorphism. This splice site variant destroys the canonical splice acceptor site in intron 5, which is predicted to cause abnormal gene splicing. The c.486-1G>A variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.486-1G>A as a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at